FINASTERIDE by Teva is androgen, 5α-dihydrotestosterone (dht). Approved for prostatectomy, symptomatic progression of bph (a confirmed ≥4 point increase in american urological association (aua) symptom score) (), symptomatic progression of bph (a confirmed ≥4 point increase in american urological association (aua) symptom score). First approved in 2013.
Drug data last refreshed 4h ago
androgen, 5α-dihydrotestosterone (DHT). Type II 5α-reductase metabolizes testosterone to DHT in the prostate gland, liver and skin. DHT induces androgenic effects by binding to androgen receptors in the cell nuclei of these organs. Finasteride is a competitive and specific inhibitor of Type II…
Worked on FINASTERIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy
A Trial of PROSCAR (Finasteride) Versus Placebo in Men With an Initial Negative Prostate Biopsy